Even after rising 3.9% this past week, Pfizer (NYSE:PFE) shareholders are still down 25% over the past three years

Pfizer Inc. (NYSE:PFE) has seen a decline in its share price over the past three years, falling short of market returns. While recent signs show promise, long-term investors have faced challenges. Analyzing EPS and shareholder returns can provide insights into market sentiment and company performance.